MoneyWorks4Me

The Sales for the quarter ended March 2022 of Rs. 1025.42 millions rose by 28.88% from Rs. 795.65 millions.The Net proft of the company remain more or less same to Rs. 110.24  millions from Rs. 125.71 millions ,decline by -12.31%.Operating profit surged to 193.26 millions from the corresponding previous quarter of 178.17 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 1025.42 795.65 28.88 4720.79 4229.08 11.63 4720.79 4229.08 11.63
Other Income 18.91 23.86 -20.75 99.98 57.43 74.09 99.98 57.43 74.09
PBIDT 193.26 178.17 8.47 1054.68 927.83 13.67 1054.68 927.83 13.67
Interest 5.66 5.68 -0.35 14.51 15.52 -6.51 14.51 15.52 -6.51
PBDT 187.60 172.49 8.76 1040.17 912.31 14.01 1040.17 912.31 14.01
Depreciation 19.98 18.92 5.60 80.88 75.60 6.98 80.88 75.60 6.98
PBT 167.62 153.57 9.15 959.29 836.71 14.65 959.29 836.71 14.65
TAX 57.38 27.86 105.96 265.74 214.21 24.06 265.74 214.21 24.06
Deferred Tax 5.64 -3.57 -257.98 7.20 2.47 191.50 7.20 2.47 191.50
PAT 110.24 125.71 -12.31 693.55 622.50 11.41 693.55 622.50 11.41
Equity 200.30 200.30 0.00 200.30 200.30 0.00 200.30 200.30 0.00
PBIDTM(%) 18.85 22.39 -15.84 22.34 21.94 1.83 22.34 21.94 1.83
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..